CellScape logo — Bringing accessible, non-invasive prenatal genetic testing t...

CellScape

Bringing accessible, non-invasive prenatal genetic testing to every woman through pioneering whole fetal cell technology

Founded 2008 Series B Total: $21.30M Biotechnology, Health Care

General Information

Company Name CellScape
Founded Year 2008
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care
Funding Stage Series B
Social

Get notified when CellScape moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CellScape

CellScape is a biotech startup focused on revolutionizing prenatal genetic testing with their pioneering whole fetal cell technology. The company, formerly known as Saryna Medical Corp, is situated in the thriving biotech hub of Newark, California. Founded in 2008, CellScape's primary mission is to make comprehensive prenatal genetic testing accessible to all women without the need for invasive procedures that could pose risks to the fetus. The leadership team's successful track record in bringing innovative and cost-effective medical and molecular diagnostics to the market adds credibility to the venture. Their latest funding round was a Series B investment on May 10, 2013. Despite the absence of specific investors provided, this investment demonstrates ongoing support and interest in their groundbreaking technology. With a focus on biotechnology and healthcare, CellScape holds promise for making significant strides in improving prenatal care and genetic screening.

Taxonomy: prenatal genetic testing, whole fetal cell technology, non-invasive testing, biotech innovation, molecular diagnostics, blood test technology, women's healthcare, startup, biotech hub, San Francisco Bay Area, innovative healthcare, genetic testing, cost-effective diagnostics, fetal health

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• - 10 May 2013
Series B •••••• - 08 May 2013
Venture Round •••••• 2
Investor Investor
01 Jul 2012
Series B •••••• 2
Investor Investor
01 Feb 2012
Series A •••••• 2
Investor Investor
01 Dec 2010

View All 6 Funding Rounds

CellScape Alternatives & Competitors

CellScape vs

Advancing genetic insights to shape a healthier future through comprehensive genomic analysis.

Biotechnology, Health Care
CellScape vs
Cradle Genomics
Cradle Genomics United States

Knowledge for Life

Corporate Round
4 employees
Biotechnology
CellScape vs

For over two decades, CGC Genetics has been a leading provider of specialty genetic tests and has gr...

Private Equity
56 employees
Biotechnology, Health Care

FAQ About CellScape

Bringing accessible, non-invasive prenatal genetic testing to every woman through pioneering whole fetal cell technology
CellScape was founded in 2008.
CellScape operates in the following industries: Biotechnology, Health Care.
CellScape has completed 6 funding rounds, raising a total of $21.30M. The latest funding stage is Series B.
Top alternatives and competitors to CellScape include Gene Health, Cradle Genomics, CGC Genetics / CGC Centro Genetica Clinica, Ecegen Genetik Hastalıklar Değerlendirme Merkezi, G2M | Next Generation IVD solutions for Genomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CellScape and Gene Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CellScape and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy